13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 33 holding rows worth $384,648,000.
- Accession
- 0001144204-15-065143
- Filer
- CIK 1633313
- Filed
- 2015-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 36 entries on the cover page, a total value of $384,648,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $384,648,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 4,250,199 | $59,460,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,453,055 | $50,014,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 2,124,593 | $23,965,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 1,103,093 | $22,801,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 804,299 | $22,351,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 581,900 | $19,243,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HOLDINGS | 71426V108 | COM | 6,004,564 | $18,974,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 3,180,913 | $18,322,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 2,151,437 | $18,051,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 5,506,618 | $15,088,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 469,025 | $15,060,000 | thousands by filing date | |
| IGI LABORATORIES INC | 449575109 | COM | 1,779,782 | $11,640,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 806,300 | $10,966,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,199,137 | $10,116,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 363,250 | $8,478,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 1,315,600 | $7,867,000 | thousands by filing date | |
| NANTKWEST INC | 63016Q102 | COM | 728,887 | $7,301,000 | thousands by filing date | |
| Innocoll | 45780Q103 | SPONDS ADR | 502,422 | $6,290,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 440,606 | $5,807,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 406,470 | $5,252,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 1,280,000 | $4,979,000 | thousands by filing date | put |
| VERACYTE INC COM | 92337F107 | Stock | 772,297 | $3,622,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 255,097 | $3,351,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 1,275,521 | $3,316,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 1,135,120 | $3,076,000 | thousands by filing date | |
| Alliqua BioMedical Inc | 019621200 | COM NEW | 850,000 | $2,695,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 410,300 | $2,170,000 | thousands by filing date | |
| HEAT BIOLOGICS INC | 42237K102 | COM | 341,064 | $1,576,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 178,300 | $1,237,000 | thousands by filing date | call |
| CELLECTIS ADS | 15117K103 | COM | 35,000 | $923,000 | thousands by filing date | |
| CATALYST | 14888D109 | COM | 83,901 | $391,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 500,000 | $153,000 | thousands by filing date | call |
| KITE PHARMA INC | 49803L109 | COM | 26,000 | $113,000 | thousands by filing date | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-15-065143 | this filing | 2015-11-13 | acceptance time not in the bulk data set |